Breast Cancer Research Foundation
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · H. Borghaei, L. Paz-Ares, et al. · New England Journal of Medicine
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · Caroline Robert, Jacob Schachter, et al. · New England Journal of Medicine
Triple-Negative Breast Cancer
2010 · William D. Foulkes, Ian E. Smith, et al. · New England Journal of Medicine